Pharmaceutical giant Merck has added a new medication for pulmonary arterial hypertension to its 340B contract pharmacy restrictions.

Merck Adds Biologic to Contract Pharmacy Restrictions

April 18, 2024 Shannon Young, Associate Editor/Senior Writer 340B Report Views

Merck has added an injectable medication used to treat pulmonary arterial hypertension—a type of high blood pressure which affects the [...]

Please Login or Become a Paid Subscriber to View this Content

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!